Genentech's All Good
520213
The biotech's latest partnership deal is nothing to worry about.
73002
Genentech Inc.  said on  Tuesday second-quarter net income rose 79 percent on higher  demand for cancer medicines and raised its full-year forecast,  but its stock fell as sales of colon cancer drug Avastin  disappointed investors.
442207
Genentech Inc.  said second-quarter profit on Wednesday rose 41 percent, fueled by cost cutting and growth from its cancer drug Avastin.
617405
Genentech Inc. said on Thursday it has  updated information on the package insert for its colon cancer  drug Avastin to reflect an increased risk of blood clots that  can cause heart attacks and stroke.
490203
Well, I had my second date with Margot last week. It was nice. We attended a seminar on multimodal component interfaces and then went on a romantic stroll around a waste treatment facility. She says the smell of methane calms her nerves. I sure can pick âem, canât I?
44693
Celera Genomics Group of Rockville announced an agreement Tuesday to provide potential targets for cancer drugs to biotech giant Genentech Inc. -The Washington Post
505962
Cephalon gets some good news about its drug PROVIGIL.
281372
Better test results for Elan Corp's key  Antegren drug lifted the Irish company's shares more than 10  percent as analysts said the data improved its chances of  becoming the leading multiple sclerosis treatment.
421816
THURSDAY, June 21 (HealthDay News) -- In an early trial, gene therapy has proven both safe and effective in easing the symptoms of Parkinson&#39;s disease, researchers say.
498476
Genentech Inc.  on Monday said its  colon cancer drug Avastin extended the life of patients when  used in combination with a chemotherapy regimen called FOLFOX4  more than the chemotherapy alone in a late stage clinical  trial.
468910
Biomira reports favorable Phase II test results.
234249
Moving to strengthen its offerings to treat cancer, Biogen Idec Inc. of Cambridge yesterday signed a deal to license tumor-killing technology from ImmunoGen Inc.
704563
Genentech's cancer drug Avastin helped patients with advanced kidney cancer live twice as long as those on standard therapy alone, according to a study released on Saturday.
421575
Genentech and OSI Pharmaceuticals won federal approval yesterday to sell Tarceva, a pill to treat lung cancer. The approval by the Food and Drug Administration came well before the agency&#39;s
240917
Genentech Inc.  on Wednesday said second-quarter profit rose 41 percent, fueled by growth from key cancer drugs Avastin and Rituxan, and it boosted its full-year profit forecast.
683680
Genentech said a low dose of its cancer drug worked just as well as a more expensive high dose in a clinical trial.
350586
SAN FRANCISCO - A novel colon cancer-fighting drug developed by Genentech Inc. already on its way to blockbuster status got an additional boost Monday when the company announced Avastin helped some of the